About us
Products
Careers
Investor Relations
News
Cares
Language:
- Italiano
- English

Home » News » PHARMANUTRA OBTAINS A PATENT FOR CETILAR® RM

PHARMANUTRA OBTAINS A PATENT FOR CETILAR® RM

Published: 06 April 2018 12:07

<< Articolo precedente Next Article >>

Related News

PharmaNutra at the Aim Italia Conference driven...

Yesterday in London, the key event focusing on Italian companies in the AIM segment. BUY rating with...
Double figure growth continues for PharmaNutra...

The Board of Directors approves the draft balance sheet and consolidated financial statement as of 31...

Related Products

Bonecal

Bonecal is a nutritional supplement that contains algal Calcium, Vitamin K2 and Vitamin D3, which aid...
DiKappa2

Dikappa2 is a nutritional supplement containing Vitamin K2 and Vitamin D which promotes intestinal calcium...

Pharmanutra SpA is a pharmaceutical company based in Pisa. It was founded in 2003 with the aim of developing nutraceuticals and medical devices. Pharmanutra follows rigorous standards of quality by maintaining a high attention to the raw materials used, unique and exclusive for the whole national territory.

PharmaNutra Spa | Registered office

Via Delle Lenze, 216/b

56122 Pisa

Tel. +39 050 7846500

Fax +39 050 7846524

C.F. / P.Iva / Reg. Impr. 01679440501

Codice Destinatario Fatturazione Elettronica SUBM70N

Cap.Soc. € 1.123.097,70

I.V. | REA 146259

Privacy policy
Cookie policy
General conditions
Code of ethics
Mod. 231

NEWSLETTER

Subscribe to the Pharmanutra newsletter and you will be constantly updated on all our activities.

Read Newsletter Disclosure

AWARDS

QUALITY

© Copyright - PHARMANUTRA.IT

All Rights Reserved.

This site is set to allow the use of all cookies in order to ensure a better navigation. If you continue to browse, you accept our cookies use. Read More